Bladder cancer: Nomogram aids clinical decision making after radical cystectomy

Nature Reviews Urology

Volumn 7, Issue 4, 2010, Pages 182-184

  Shariat, Shahrokh F ^a   Tilki, Derya ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CASPASE 3; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; SURVIVIN;

ACCURACY; ADJUVANT THERAPY; APOPTOSIS; BLADDER CANCER; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE REGULATION; CELL PROLIFERATION; CYSTECTOMY; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; MORBIDITY; NOMOGRAM; PATIENT REFERRAL; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK BENEFIT ANALYSIS; SHORT SURVEY; TREATMENT RESPONSE;

CYSTECTOMY; HUMANS; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; URINARY BLADDER NEOPLASMS;

EID: 77950998537     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.42     Document Type: Short Survey

References (10)

1. shariat, s. F., Karakiewicz, P. i., Roehrborn, C. G. & Kattan, M. w. An updated catalog of prostate cancer predictive tools. Cancer 113, 3075-3099 (2008).
2. shariat, s. F., Margulis, v., Lotan, Y., Montorsi, F. & Karakiewicz, P. i. nomograms for bladder cancer. Eur. Urol. 54, 41-53 (2008).
3. Karakiewicz, P. i. et al. nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J. Urol. 176, 1354-1361; discussion 1361-1362 (2006).
4. shariat, s. F. et al. nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin. Cancer Res. 12, 6663-6676 (2006).
5. international Bladder Cancer nomogram Consortium, Bochner, B. H., Kattan, M. w. & vora, K. C. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J. Clin. Oncol. 24, 3967-3972 (2006). (Pubitemid 46630745)
6. vickers, A. J., Cronin, A. M., elkin, e. B. & Gonen, M. extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med. Inform. Decis. Mak. 8, 53 (2008).
7. vickers, A. J. et al. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer 115, 5460-5469 (2009).
8. shariat, s. F. et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 112, 315-325 (2008).
9. Margulis, v. et al. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J. Natl Cancer Inst. 101, 114-119 (2009).
10. Karam, J. A. et al. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol. 8, 128-136 (2007).